---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-142114"
form_type: "8-K"
ticker: "CLYM"
cik: "0001768446"
company_name: "Climb Bio, Inc."
filed_at: "2026-04-03T23:59:59+00:00"
generated_at: "2026-05-15T07:38:37.090293+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Climb Bio SVP Finance to depart April 30; CFO adds principal accounting officer role

## Summary
- Cindy Driscoll, SVP Finance and principal accounting officer, to separate from Climb Bio effective April 30, 2026, by mutual agreement.
- CFO Susan Altschuller will also serve as principal accounting officer starting on the Separation Date.
- Altschuller has been CFO since Oct 2025; prior CFO roles at Dragonfly Therapeutics, Cerevel Therapeutics, and ImmunoGen.

## SEC filing metadata
- accession: 0001193125-26-142114
- form_type: 8-K
- ticker: CLYM
- cik: 0001768446
- company_name: Climb Bio, Inc.
- filed_at: 2026-04-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1768446/000119312526142114/0001193125-26-142114-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1768446/000119312526142114/d59877d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-142114
- JSON: https://secwatch.observer/filing/0001193125-26-142114.json
- Plain text: https://secwatch.observer/filing/0001193125-26-142114.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.